View Scopus Profile

Robert Leo Murphy

Professor, Medicine, Infectious Diseases Division
Professor, Biomedical Engineering
John Philip Phair Professor in Infectious Diseases, Surgery, Surgical Oncology Division
Center Director, Global Health Institute
Member, IIN - International Institute for Nanotechnology
Member, PAS - Program of African Studies

Phone+1 312 503 9000
Emailr-murphy@northwestern.edu

Source: Scopus

Research activity per year

If you made any changes in Pure these will be visible here soon.

34 Active
80 Finished

1 - 25 out of 80 results

Filter

The Atlantic Study: A Randomized, Open-Label Strategic Study to Evaluate the Safety and Efficacy of 3 Different Convergent and Divergent Drug Combination Therapies in Anti-Retroviral Naive HIV-1 Infected Patients with CD4+ Counts above 200/mm3
Murphy, R. L.
Academic Medical Centre at the University of Amsterdam, Bristol-Myers Squibb Pharmaceutical Research Institute
3/1/97 → 11/8/10
Project: Research project
Protocol # M97-720: Phase I/II Study of ABT-378/Ritonavir in Combination with Reverse Transcriptase Inhibitors in Antiretroviral Naive HIV-Infected Patients
Murphy, R. L.
PPD Development, Abbott Laboratories
11/7/97 → 6/23/06
Project: Research project
Supplemental Funding for the Northwestern Adult AIDS Clinical Trials Group
Murphy, R. L.
Social & Scientific Systems, Inc.
1/1/98 → 4/10/07
Project: Research project
Protocol # CS-L2004C: A Multi-Center Compassionate Use Protocol for Proleukin (Aldesleukin) and Antiretroviral Therapy in HIV Seropositive Patients Who Have Successfully Completed a Chiron-Sponsored Proleukin Trial
Murphy, R. L.
Chiron Corporation
1/26/98 → 8/12/08
Project: Research project
Study of the Ocular Complications of AIDS (SOCA)
Jampol, L. M., Murphy, R. L. & Lyon, A.
Johns Hopkins University, Kennedy Institute - National Eye Clinic
8/1/98 → 7/31/10
Project: Research project
Study of the Ocular Complications of AIDS (SOCA) Patient Care
Murphy, R. L., Lyon, A. & Lyon, A.
Johns Hopkins University, Kennedy Institute - National Eye Clinic
8/1/98 → 7/31/08
Project: Research project
Northwestern Adult AIDS Clinical Trials Unit
Wolinsky, S. M., Wolinsky, S. M., Lowe Jr, W. L., Lowe Jr, W. L., Phair, J. P., Phair, J. P., Garcia, P. M., Garcia, P. M., Murphy, R. L., Palella Jr, F. J., Palella Jr, F. J., Hirschtick, R. E., Hirschtick, R. E., Pelzer, H. J., Pelzer, H. J., Cohen, B. A., Cohen, B. A., Hoff, F. L. & Sutton, S. H.
National Institute of Allergy and Infectious Diseases
1/1/00 → 12/31/07
Project: Research project
Prot# SILCAAT: A Phase III Multicenter Randomized Study of the Biological and Clinical Efficacy of Subcutaneous Recombinant, Human Interleukin-2 in HIV-Infected Patients with Low CD4+ Counts Under Active Antiretroviral Therapy (the "SILCAAT Trial")
Murphy, R. L.
University of Minnesota, Chiron Corporation
2/18/03 → 12/31/08
Project: Research project
Regional Center for Excellence for Bioterrorism: Molecular Analysis and Intervention: Emergency Response Plan Component
Wolinsky, S. M., Murphy, R. L., Stosor, V., Zembower, T. R. & Zembower, T. R.
University of Chicago, National Institute of Allergy and Infectious Diseases
9/4/03 → 2/28/09
Project: Research project
Northwestern Adult AIDS Clinical Trials Unit
Murphy, R. L.
National Institute of Allergy and Infectious Diseases
1/1/04 → 12/31/07
Project: Research project
Prot# Tibotec TMC114-C202: A Phase II Randomized, Controlled, Partially Blinded, 48-Week Trial to Investigate Dose-Response of TMC114/RTV in 3-Class-Experienced, Multi PI-Experienced HIV-1 Infected Subjects
Murphy, R. L.
Inveresk Research, Inc., Tibotec Pharmaceuticals Ltd.
2/9/04 → 8/12/08
Project: Research project
Rapid Expansion of Antiretroviral Therapy Programs (PEPFAR)
Murphy, R. L. & Taiwo, B. O.
Harvard University, Health Resources and Services Administration
3/1/04 → 2/28/09
Project: Research project
CIPRA
Murphy, R. L.
Harvard University, National Institute of Allergy and Infectious Diseases
3/1/04 → 2/28/06
Project: Research project
Prot# SNAP: Switching Nucleoside Analogues Protocol - Lipoatrophy and Mitochondrial Function
Murphy, R. L.
Abbott Laboratories
4/4/04 → 11/4/06
Project: Research project
Prot# TMC125-C223: A Randomized, Controlled, Partially Blinded Phase IIb Dose-Finding Trial of TMC125, in HIV-1 Infected Subjects with Documented Genotypic Evidence of Resistance to Currently Available NNRTIs and With at Least Three Primary PI Mutations
Murphy, R. L.
PPD Development, Tibotec Pharmaceuticals Ltd.
7/20/04 → 8/8/07
Project: Research project
Prot# INCB 8721 RVT-203: A Placebo-Controlled, Double-Blind, Parallel Dose Group Study Exploring the Safety, Tolerability, & Virological Effect of 50, 100, & 200mg Reverset? (RVT) in HIV-Infected Antiretroviral Therapy-Experienced Subjects When Used in Co
Murphy, R. L.
Quintiles, Inc., Incyte Corporation
9/8/04 → 4/13/07
Project: Research project
Prot# MANON 02: A Phase II, Randomized, Placebo-Controlled Study to Evaluate the Immunogenicity and the Safety of Two Schedules of an Homologous Prime-Boost with the ALVAC-HIV vCP1452 in Chronically HIV-Infected Patients
Murphy, R. L.
ORVACS
11/29/04 → 12/31/07
Project: Research project
Prot# AI424-075: The SABAR Study: Switch to Atazanavir and Brachial Artery Reactivity (SABAR) Study: Endothelial Function in HIV-Infected Subjects Switched to an Atazanavir Regimen
Murphy, R. L.
Bristol-Myers Squibb Company
2/15/05 → 10/22/10
Project: Research project
Prot# TMC114-C215: An Open Label Trial of TMC114/RTV in HIV-1 Infected, Treatment-Experienced Subjects
Murphy, R. L.
Medisearch International Corp., Tibotec Pharmaceuticals Ltd.
3/31/05 → 9/2/08
Project: Research project
Prot# A4001026: A Mltcntr, Rndmzd, Dbl-Blind, Comparative Trial Of a Novel CCR5 Antagonist, UK-427,857, in Combination w/Zidovudine/Lamivudine v. Efavirenz in Combination w/Zidovudine/Lamivudine for the Treatment of Antiretroviral-Naïve HIV-1 Infected Sbj
Murphy, R. L.
Quintiles, Inc., Pfizer Inc.
6/6/05 → 8/8/07
Project: Research project
Nanoemulsions as Adjuvants for Nasal-Spray Vaccines
Murphy, R. L.
University of Michigan, Bill & Melinda Gates Foundation
7/1/05 → 6/30/09
Project: Research project
PROsIT: A Total Patient-Reported Outcomes Solution
Murphy, R. L. & Flaherty, J. P.
BrightOutcome Inc., National Institute of Mental Health
7/19/05 → 7/18/08
Project: Research project
Prot# TMC125-C229: An Open-Label Trial with TMC125 in HIV-1 Infected Subjects, Who Were Randomized to a TMC125 Treatment Arm in a Sponsor-Selected TMC125 Trial and Were Treated for at Least 48 Weeks
Murphy, R. L.
PPD Development, Tibotec Pharmaceuticals Ltd.
9/7/05 → 8/12/08
Project: Research project
A Retrospective Study to Compare the 3-Year Antiviral Efficacy of Nevirapine and Efavirenz in Combination with D4T and 3TC in 2NN Patients
Murphy, R. L.
Boehringer Ingelheim Pharmaceuticals, Inc., International Antiviral Therapy Evaluation Center B.V.
10/10/05 → 5/31/06
Project: Research project
Directly Observed, Community-Based Treatment in Nigeria
Murphy, R. L. & Taiwo, B. O.
Doris Duke Charitable Foundation
1/1/06 → 6/30/08
Project: Research project